Objectives |
-
(i)
To assess the contribution of existing literature of association of electronic cigarette use and metabolic syndrome development as well as its individual components (insulin resistance, diabetes, dyslipidemia, obesity, blood pressure).
-
(ii)
To compare the impact of e-cigarettes use and smoking conventional cigarettes on metabolic syndrome
-
(iii)
To identify relevant information and outline existing knowledge
-
(iv)
To identify any gap in the existing research
|
Research question |
-
(i)
Does electronic cigarette use have a significant impact on metabolic syndrome development?
-
(ii)
Does electronic cigarette use have a significant impact on the occurrence of metabolic syndrome components (insulin resistance, diabetes, dyslipidemia, obesity, blood pressure)?
|
Keywords |
-
(i)
“electronic cigarettes” or “tobacco smoking” and “metabolic syndrome”;
-
(ii)
“electronic cigarettes” or “tobacco smoking” and “insulin resistance”;
-
(iii)
“electronic cigarettes” or “tobacco smoking” and “diabetes”;
-
(iv)
“electronic cigarettes” or “tobacco smoking” and “dyslipidemia”;
-
(v)
“electronic cigarettes” or “tobacco smoking” and “obesity”;
-
(vi)
“electronic cigarettes” or “tobacco smoking” and “blood pressure”
|